Gyrus Group Somnoplasty
This article was originally published in The Gray Sheet
Executive Summary
Minimally invasive radio frequency device gains 510(k) clearance for use in outpatient tonsil reduction procedures to treat tonsillar hypertrophy - a $150 mil. market niche in the $1 bil. head and neck surgery market. Somnoplasty is already cleared for sleep apnea, nasal obstruction and snoring...